The Health History of First-Degree Relatives’ Dyslipidemia Can Affect Preferences and Intentions following the Return of Genomic Results for Monogenic Familial Hypercholesterolemia

Author:

Tokutomi Tomoharu12ORCID,Yoshida Akiko12ORCID,Fukushima Akimune12,Yamamoto Kayono2,Ishigaki Yasushi1ORCID,Kawame Hiroshi3ORCID,Fuse Nobuo3,Nagami Fuji3,Suzuki Yoichi3,Sakurai-Yageta Mika3ORCID,Uruno Akira3,Suzuki Kichiya3,Tanno Kozo1ORCID,Ohmomo Hideki1ORCID,Shimizu Atsushi1,Yamamoto Masayuki3ORCID,Sasaki Makoto1

Affiliation:

1. Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Shiwa 020-3694, Japan

2. Department of Clinical Genetics, School of Medicine, Iwate Medical University, Morioka 020-8505, Japan

3. Tohoku Medical Megabank Organization, Tohoku University, Sendai 980-8573, Japan

Abstract

Genetic testing is key in modern healthcare, particularly for monogenic disorders such as familial hypercholesterolemia. This Tohoku Medical Megabank Project study explored the impact of first-degree relatives’ dyslipidemia history on individual responses to familial hypercholesterolemia genomic results. Involving 214 participants and using Japan’s 3.5KJPN genome reference panel, the study assessed preferences and intentions regarding familial hypercholesterolemia genetic testing results. The data revealed a significant inclination among participants with a family history of dyslipidemia to share their genetic test results, with more than 80% of participants intending to share positive results with their partners and children and 98.1% acknowledging the usefulness of positive results for personal health management. The study underscores the importance of family health history in genetic-testing perceptions, highlighting the need for family-centered approaches in genetic counseling and healthcare. Notable study limitations include the regional scope and reliance on questionnaire data. The study results emphasize the association between family health history and genetic-testing attitudes and decisions.

Funder

Japan Agency for Medical Research and Development

Publisher

MDPI AG

Reference28 articles.

1. Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022;Arai;J. Atheroscler. Thromb.,2023

2. Family Health History: Underused for Actionable Risk assessment;Ginsburg;Lancet,2019

3. Family history assessment significantly enhances delivery of precision medicine in the genomics era;Bylstra;Genome Med.,2021

4. Systematic comparison of family history and polygenic risk across 24 common diseases;Mars;Am. J. Hum. Genet.,2022

5. Genetic risk, adherence to a healthy lifestyle, and coronary disease;Khera;N. Engl. J. Med.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3